Skip to search formSkip to main contentSkip to account menu

ferumoxtran-10

Known as: USPIO, Ultrasmall Particulate Iron Oxide, ferumoxtran 
A substance being studied as a way of improving magnetic resonance imaging (MRI) in diagnosing cancer and finding lymph nodes to which cancer has… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
Background and Purpose— A growing body of evidence suggests that inflammatory processes are involved in the pathophysiology of… 
Review
2006
Review
2006
OBJECTIVE Ferumoxtran-10 is a lymphotropic MR contrast agent that is currently under investigation. It has been shown to be… 
Highly Cited
2006
Highly Cited
2006
Objectives:We sought to compare the ability of 3 ultrasmall superparamagnetic iron oxides (USPIOs) to detect and characterize… 
Highly Cited
2006
Highly Cited
2001
Highly Cited
2001
Cells of the mononuclear phagocytotic system (MPS) are often found near to or within ischemic tissue and can potentially… 
Highly Cited
2001
Highly Cited
2001
A preparation of ultra‐small superparamagnetic iron oxide (USPIO) particles coupled to an RGD peptide (RGD‐USPIO) was… 
Review
1997
Review
1997
Accurate diagnosis of cervical lymph node metastasis is challenging, even with the latest computed tomography or MR equipment and… 
Highly Cited
1991
Highly Cited
1991
An ultrasmall superparamagnetic iron oxide (USPIO) preparation was evaluated as a potential intravenous contrast agent for…